Antiestrogen resistant breast cancer cells with higher MYC activation showed increased sensitivity to small molecule inhibitors of glutaminolysis and glycolysis (Figure 5C), but did not re-sensitize these cells to antiestrogens. The gene discussed is MYC; the disease is breast carcinoma.